Related Experiment Videos
Effect of particle dissolution rate on ocular drug bioavailability
Journal of Pharmaceutical Sciences
|March 1, 1986
Summary
This study introduces a new kinetic model to predict ocular drug levels from suspensions. The model accounts for particle size, concentration, and drainage, improving bioavailability predictions for ophthalmic drugs.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Drug Delivery
Background:
- Aqueous ophthalmic solutions have low bioavailability due to tear drainage, turnover, and absorption.
- Drug suspensions may enhance bioavailability but require consideration of dissolution rate, solubility, and residence time.
- The interplay of factors influencing ophthalmic drug suspension dissolution has not been fully elucidated.
Purpose of the Study:
- To develop and validate a kinetic model for predicting ocular drug concentrations from suspensions.
- To investigate the impact of particle size, drug concentration, and drainage rate on ocular drug levels.
- To establish a predictive tool for optimizing ophthalmic drug suspension formulations.
Main Methods:
- Development of a novel kinetic model for ocular drug delivery from suspensions.
- Testing the model using fluorometholone, a steroid drug suspension.
- Simulating the effects of varying particle size, concentration, and drainage rates.
Main Results:
- The developed kinetic model successfully predicts ocular tissue drug levels for suspensions.
- The model demonstrates the influence of particle size, concentration, and drainage on drug bioavailability.
- A reasonable a priori prediction of drug levels is achievable with the proposed model.
Conclusions:
- The kinetic model provides a valuable tool for understanding and predicting ocular drug levels from suspensions.
- This model can aid in the rational design of ophthalmic drug suspensions with improved bioavailability.
- Further research can refine the model for broader applications in ophthalmic drug development.